Only show
results from:

Sort results by:

Display preferences
9,358 results sorted by relevancy Results per page:
Abbott Again Honored as a Leader in Diversity.
PR Newswire; Oct 26, 2007; 700+ Words ...magazine. In addition, Abbott was named one of the...Engineer and Information Technology magazine. "At Abbott, we value the diversity of our products, technologies, markets and most importantly...Human Resources, Abbott. "Having a diverse...Sales and Marketing Inc., based on ...
Abbott Laboratories Declares Special Dividend Distribution of Hospira Stock.
PR Newswire; Apr 12, 2004; 700+ Words ...common stock of Hospira, Inc., the global hospital...company being spun off by Abbott. For every 10 shares...another milestone in Abbott's strategy to accelerate...innovations in advanced-technology medical products and pharmaceuticals." Abbott has received a ruling...
Abbott Laboratories Declares Special Dividend Distribution of Hospira Stock; - Abbott Confirms Previously Announced Earnings-Per-Share Guidance for Second-Quarter and Full-Year 2004, Adjusted for the Shift of Earnings to Hospira -.
PR Newswire; Apr 12, 2004; 700+ Words Abbott Laboratories today announced...common stock of Hospira, Inc., the global hospital...company being spun off by Abbott. For every 10 shares...innovations in advanced- technology medical products and pharmaceuticals." Abbott has received a ruling...
Abbott Laboratories Licenses Protein Design Labs' Intellectual Property for Antibodies Binding to Interleukin-12 (IL-12) and the IL-12 Receptor.
PR Newswire; Dec 23, 2003; 700+ Words Abbott Laboratories and Protein Design Labs, Inc. (PDL) today...agreement that provides Abbott certain exclusive...s humanization technology. IL-12 is a...Abbott's unique technology platform comprising...proprietary and licensed technologies, a ten-year...therapeutics. ...
Abbott Laboratories Obtains Exclusive License to Yeast Display Technology Through Acquisition of Virtual Company, BioDisplay Technologies, Inc.
PR Newswire; Dec 21, 2001; 700+ Words ...exclusive license to yeast display technology from the University of Illinois...virtual company, BioDisplay Technologies, Inc. Abbott is acquiring BioDisplay Technologies, Inc. for $7 million. The technology will become part of the antibody...
Abbott Laboratories Reviews 2002 Accomplishments At Annual Shareholders Meeting; - Abbott CEO Stresses Commitment to Science, Innovation and Execution -.
PR Newswire; Apr 25, 2003; 700+ Words ...the annual meeting of Abbott Laboratories shareholders...Medical Analysis Systems, Inc. for the VecTest(TM...mosquitoes and birds. Abbott is also developing a...stent delivery system. Abbott also recently launched...dexamethasone, with PC Technology(TM), an innovative...
Abbott Laboratories Acquisition of Vysis, Inc. Clears Antitrust Review.
PR Newswire; Nov 23, 2001; 700+ Words ...stockholder approval, Abbott intends to consummate...transaction with Vysis, Abbott has entered into an agreement with Amoco Technology Company (ATC), an...subsidiary of BP America Inc. and owner of approximately...with the agreement. Abbott Laboratories is a global...
Abbott and Protein Design Labs Announce Broad, Long-Term Collaboration for Humanized Therapeutic Antibodies.
PR Newswire; Jun 7, 2004; 700+ Words Abbott Laboratories...Design Labs, Inc. (PDL) today...that provides Abbott broad access to PDL's technology for antibody...PDL's proven technology and our ability...as Abbott." Abbott currently has...MedImmune Inc. and Abbott...
Abbott Partners With Metabolex to Develop Diabetes Products
PR Newswire; Jun 24, 1997; 700+ Words ...will collaborate with Abbott on the discovery of drugs...terms of the agreements, Abbott made a $4 million equity...acquisition of MediSense, Inc. last year and our strong...products, emphasize Abbott's intention to be a...diagnostic and therapeutic technologies to improve the care of...
Abbott Laboratories Reviews 2003 Accomplishments at Annual Shareholders' Meeting; - Abbott CEO Highlights Transformation of the Company Into a Higher-Growth Business -.
PR Newswire; Apr 23, 2004; 700+ Words ...five years to transform Abbott into a higher-growth...innovative business. "Abbott today is evolving into...Using best-in-class technologies, we've also doubled...portfolio of advanced-technology, high-growth medical...continued evolution of Abbott's broad-based approach...included ...
Abbott Laboratories Exercises Option From Hayashibara To Antibodies Against Cytokine IL-18; - Exclusive License To Develop Novel Treatment For Autoimmune & Inflammatory Diseases -.
PR Newswire; Jan 9, 2002; 700+ Words ...collaboration between Abbott's Worcester, Mass...based biotech facility, Abbott Bioresearch Center...Biochemical Laboratories, Inc. (HBL), based in...Pharmaceutical Discovery, Abbott Laboratories, and president...include ABC's unique technology platform comprising...proprietary and ...
Abbott Laboratories Reviews Pharmaceutical Research and Development Transformation at Meeting for Investors and Financial Analysts; Promising Atrasentan and ABT-874 Data; Near-Term Opportunities in Pain Franchise; and Increase in HUMIRA(TM) (adalimumab) forecasts for 2003.
PR Newswire; May 29, 2003; 700+ Words ...by utilizing advanced technologies that allow us to discover...company indicated that Abbott has a strong pipeline...compounds through 2006. Abbott's global pharmaceutical...pharmaceutical model at Abbott that's more focused...Pharmaceutical Products Inc., Abbott's joint...
Abbott and Biocurex Enter Into Agreement for RECAF(TM) Cancer Technology; - An Emerging Cancer Biomarker, RECAF is Found on Malignant Cells From a Variety of Cancer Types and May Be Useful in the Development of New Cancer Tests -.
PR Newswire; Mar 29, 2005; 700+ Words ...patented/proprietary technology in the area of cancer...diagnostics. In 1991, Abbott developed the first automated...diagnostic analyzers. Abbott's innovative genomic...therapy for breast cancer. Abbott is a global, broad...7870, for BioCurex, Inc.; or Financial Community...
ABBOTT TAPS SPINAL MARKET; Some docs skeptical; J & J a competitor.(News)(Wallis System)
Crain's Chicago Business; Aug 22, 2005; ; 700+ Words ...White's plan to reduce Abbott's reliance on prescription...treatments also plunges Abbott into a debate among U...so infatuated with the technology, but how do these people...Charite. Medtronic Inc., the largest maker...figures for Charite. Abbott points out that Wallis...
Abbott Completes Acquisition of Evalve, Inc.
PR Newswire; Nov 2, 2009; 700+ Words ABBOTT PARK, Ill., Nov...PRNewswire-FirstCall/ -- Abbott announced today that...acquisition of Evalve, Inc., the global leader...acquisition provides Abbott with a leading presence...innovative valve repair technology gives us the potential...
ABBOTT LABORATORIES ACQUIRES CONTROL OF MEDISENSE, INC.
PR Newswire; May 2, 1996; 700+ Words ...MediSense is the biosensor technology leader in blood glucose...industry-leading technology in glucose monitoring...program will augment Abbott's existing work to...invasive monitoring technologies," said White. Abbott Laboratories is a worldwide...Laboratories; MediSense, Inc. ST: ...
ABBOTT'S $7.3-BIL. ALZA ACQUISITION COULD TURN OFF TAP: DEAL SETS UP OVERLAP WITH JOINT VENTURE.
Crain's Chicago Business; Jun 28, 1999; ; 700+ Words ...drug-delivery technology -- sustained...will bolster Abbott's product expansion...the benefits to Abbott, TAP faces major...California's Amgen Inc. and New Jersey...such as Pfizer Inc., Novartis AG...competitors of Abbott. Alza receives...common to share technologies in the ...
Abbott's biggest deal since '01 cheered by Street; stock up 4 percent
AP Worldstream; Jan 9, 2006; ; 700+ Words ...Dateline: CHICAGO Abbott Laboratories Inc.'s deal to buy...earlier would be Abbott's largest acquisition...reached a separate technology licensing agreement...s one reason why Abbott's stock has sagged...business into Hospira Inc. in April 2004...
Abbott Laboratories to Buy Biotech Company in Downers Grove, Ill.
Knight Ridder/Tribune Business News; Oct 25, 2001; 700+ Words ...myriad cancers, Abbott Laboratories Wednesday...biotech company Vysis Inc. for $355 million...human genome. Abbott's existing molecular...therapeutic." The technology was important enough...certainly needed new technologies, particularly...analysts say. Abbott will benefit ...
Abbott faces stent squeeze; Deal buys battle for share of crowded market.(News)
Crain's Chicago Business; Jul 10, 2006; 700+ Words ...working on next generation Abbott and its competitors already...releasing stents, including technology that allows the device...effects. In March, Abbott began the first human...looks not so great for Abbott,'' says A. G. Edwards & Sons Inc. analyst Jan David Wald...
9,358 results: 1 | 2 | 3 | 4 | 5 | Next >>

Find articles, research, and archives